arrow
F

Fraser Cummings

University of Southampton
H指数:44
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Effectiveness, Safety and Quality of Life With Ustekinumab for the Treatment of Crohn's Disease: Results of the UK Ustekinumab Real World Evidence Study (UndieS) Study Group

英夫利昔单抗治疗克罗恩病的真实世界有效性、安全性和生活质量:英国英夫利昔单抗真实世界证据研究(UndieS)研究小组的结果

2026-07-300
PRE
The UK vedolizumab real-life experience study in inflammatory bowel disease (VEST): patient characteristics, drug persistence and patient-centred outcomes

英国 Vedolizumab 真实世界经验研究在炎症性肠病(VEST):患者特征、药物持续性和以患者为中心的结局

2026-05-310
PRE
Identification of novel molecular drivers, prognostic and diagnostic biomarkers for Inflammatory Bowel Disease (IBD): protocol for the Nottingham/AstraZeneca prospective IBD observational cohort study

鉴定新型分子驱动因子、预后和诊断生物标志物,用于炎症性肠病(IBD):诺丁汉/阿斯利康前瞻性IBD观察性队列研究方案

2025-11-230
PRE
Real-world outcomes from the UK IBD Registry on second-line biologic therapy following anti-TNF exposure in Crohn’s disease: results from the BISCUITS study

英国炎症性肠病登记研究中克罗恩病患者接受抗-TNF治疗后使用二线生物制剂的疗效:BISCUITS研究的结果

2025-07-280
OA
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: Results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study
2022-08-2913
OAAI